3-Iodobenzylguanidine
The therapeutic efficacy of Iobenguane can be decreased when used in combination with Milnacipran.
4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Milnacipran.
Acarbose
Milnacipran may increase the hypoglycemic activities of Acarbose.
Advertisement
Acebutolol
The serum concentration of Acebutolol can be increased when it is combined with Milnacipran.
Aceclofenac
Milnacipran may increase the antiplatelet activities of Aceclofenac.
Acenocoumarol
The risk or severity of adverse effects can be increased when Milnacipran is combined with Acenocoumarol.
Advertisement
Acepromazine
The risk or severity of adverse effects can be increased when Acepromazine is combined with Milnacipran.
Aceprometazine
The risk or severity of adverse effects can be increased when Aceprometazine is combined with Milnacipran.
Acetaminophen
Milnacipran may increase the antiplatelet activities of Acetaminophen.
Advertisement
Acetophenazine
The risk or severity of adverse effects can be increased when Milnacipran is combined with Acetophenazine.
Acetyl salicylate
Milnacipran may increase the antiplatelet activities of Acetylsalicylic acid.
Adrafinil
Milnacipran may increase the tachycardic activities of Adrafinil.
Albiglutide
Milnacipran may increase the hypoglycemic activities of Albiglutide.
Albuterol
Milnacipran may increase the tachycardic activities of Salbutamol.
Alfaxalone
The risk or severity of adverse effects can be increased when Alfaxalone is combined with Milnacipran.
Alfentanil
Alfentanil may increase the serotonergic activities of Milnacipran.
Almotriptan
The risk or severity of adverse effects can be increased when Almotriptan is combined with Milnacipran.
Alogliptin
Milnacipran may increase the hypoglycemic activities of Alogliptin.
Alosetron
Alosetron may increase the serotonergic activities of Milnacipran.
Alphaprodine
Alphaprodine may increase the serotonergic activities of Milnacipran.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Milnacipran.
Alprenolol
The serum concentration of Alprenolol can be increased when it is combined with Milnacipran.
Aminosalicylic Acid
Milnacipran may increase the antiplatelet activities of Aminosalicylic Acid.
Amiodarone
The serum concentration of Amiodarone can be increased when it is combined with Milnacipran.
Amisulpride
The risk or severity of adverse effects can be increased when Amisulpride is combined with Milnacipran.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Milnacipran.
Amobarbital
The risk or severity of adverse effects can be increased when Amobarbital is combined with Milnacipran.
Amoxapine
Milnacipran may increase the serotonergic activities of Amoxapine.
Amphetamine
The risk or severity of adverse effects can be increased when Milnacipran is combined with Amphetamine.
Anhydrous Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Milnacipran.
Antipyrine
Milnacipran may increase the antiplatelet activities of Antipyrine.
Apomorphine
Milnacipran may increase the tachycardic activities of Apomorphine.
Apraclonidine
Milnacipran may increase the tachycardic activities of Apraclonidine.
Arbutamine
Milnacipran may increase the tachycardic activities of Arbutamine.
Arformoterol
Milnacipran may increase the tachycardic activities of Arformoterol.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Milnacipran.
Articaine
The risk or severity of adverse effects can be increased when Articaine is combined with Milnacipran.
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Milnacipran.
Asian ginseng extract
Milnacipran may increase the antiplatelet activities of Ginseng.
Aspirin
Milnacipran may increase the antiplatelet activities of Acetylsalicylic acid.
Atenolol
The serum concentration of Atenolol can be increased when it is combined with Milnacipran.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Milnacipran.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Milnacipran.
Balsalazide
Milnacipran may increase the antiplatelet activities of Balsalazide.
Bambuterol
Milnacipran may increase the tachycardic activities of Bambuterol.
Barbital
The risk or severity of adverse effects can be increased when Barbital is combined with Milnacipran.
Bendroflumethiazide
Milnacipran may increase the hyponatremic activities of Bendroflumethiazide.
Benoxinate
The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Milnacipran.
Benperidol
The risk or severity of adverse effects can be increased when Benperidol is combined with Milnacipran.
Benzocaine
The risk or severity of adverse effects can be increased when Benzocaine is combined with Milnacipran.
Benzphetamine
Milnacipran may increase the tachycardic activities of Benzphetamine.
Benzthiazide
Milnacipran may increase the hyponatremic activities of Benzthiazide.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Milnacipran.
Betaxolol
The serum concentration of Betaxolol can be increased when it is combined with Milnacipran.
Bethanidine
Milnacipran may decrease the antihypertensive activities of Bethanidine.
Betrixaban
The risk or severity of bleeding can be increased when Betrixaban is combined with Milnacipran.
Bisoprolol
The serum concentration of Bisoprolol can be increased when it is combined with Milnacipran.
Bitolterol
Milnacipran may increase the tachycardic activities of Bitolterol.
Bitolterol Mesylate
Milnacipran may increase the tachycardic activities of Bitolterol.
Bopindolol
The serum concentration of Bopindolol can be increased when it is combined with Milnacipran.
Brexpiprazole
The risk or severity of adverse effects can be increased when Milnacipran is combined with Brexpiprazole.
Brimonidine
Milnacipran may increase the tachycardic activities of Brimonidine.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Milnacipran.
Bromfenac
Milnacipran may increase the antiplatelet activities of Bromfenac.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Milnacipran.
Bromperidol
The risk or severity of adverse effects can be increased when Bromperidol is combined with Milnacipran.
Brompheniramine
The risk or severity of adverse effects can be increased when Brompheniramine is combined with Milnacipran.
Brotizolam
The risk or severity of adverse effects can be increased when Brotizolam is combined with Milnacipran.
Bufexamac
Milnacipran may increase the antiplatelet activities of Bufexamac.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Milnacipran.
Bupranolol
The serum concentration of Bupranolol can be increased when it is combined with Milnacipran.
Buprenorphine
Buprenorphine may increase the serotonergic activities of Milnacipran.
Buspirone
Buspirone may increase the serotonergic activities of Milnacipran.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Milnacipran.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Milnacipran.
Butamben
The risk or severity of adverse effects can be increased when Butamben is combined with Milnacipran.
Butobarbital
The risk or severity of adverse effects can be increased when Butethal is combined with Milnacipran.
Butorphanol
Butorphanol may increase the serotonergic activities of Milnacipran.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Milnacipran.
Canagliflozin
Milnacipran may increase the hypoglycemic activities of Canagliflozin.
Canagliflozin Anhydrous
Milnacipran may increase the hypoglycemic activities of Canagliflozin.
Capsaicin
Milnacipran may increase the antiplatelet activities of Capsaicin.
Carbamazepine
The metabolism of Carbamazepine can be decreased when combined with Milnacipran.
Carbinoxamine
The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Milnacipran.
Cariprazine
The risk or severity of adverse effects can be increased when Milnacipran is combined with Cariprazine.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Milnacipran.
Carprofen
Milnacipran may increase the antiplatelet activities of Carprofen.
Carteolol
The serum concentration of Carteolol can be increased when it is combined with Milnacipran.
Carvedilol
The serum concentration of Carvedilol can be increased when it is combined with Milnacipran.
Celecoxib
Milnacipran may increase the antiplatelet activities of Celecoxib.
Celiprolol
Milnacipran may increase the tachycardic activities of Celiprolol.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Milnacipran.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Milnacipran.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Milnacipran.
Chlormethiazole
The risk or severity of adverse effects can be increased when clomethiazole is combined with Milnacipran.
Chlormezanone
The risk or severity of adverse effects can be increased when Chlormezanone is combined with Milnacipran.
Chloroprocaine
The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Milnacipran.
Chlorothiazide
Milnacipran may increase the hyponatremic activities of Chlorothiazide.
Chlorphenesin
Milnacipran may increase the antiplatelet activities of Chlorphenesin.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Milnacipran.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Milnacipran.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Milnacipran.
Chlorpropamide
Milnacipran may increase the hypoglycemic activities of Chlorpropamide.
Chlorprothixene
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Milnacipran.
Chlorthalidone
Milnacipran may increase the hyponatremic activities of Chlorthalidone.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Milnacipran.
Choline Magnesium Trisalicyclate
Milnacipran may increase the antiplatelet activities of Choline magnesium trisalicylate.
Cimetidine
The metabolism of Milnacipran can be decreased when combined with Cimetidine.
Cisplatin
Milnacipran may increase the antiplatelet activities of Cisplatin.
Citalopram
Milnacipran may increase the serotonergic activities of Citalopram.
Clemastine
The risk or severity of adverse effects can be increased when Clemastine is combined with Milnacipran.
Clenbuterol
Milnacipran may increase the tachycardic activities of Clenbuterol.
Clidinium
The risk or severity of adverse effects can be increased when Clidinium is combined with Milnacipran.
Clidinium bromide
The risk or severity of adverse effects can be increased when Clidinium is combined with Milnacipran.
Clobazam
The risk or severity of adverse effects can be increased when Clobazam is combined with Milnacipran.
Clodronic Acid
Milnacipran may increase the antiplatelet activities of Clodronic Acid.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Milnacipran.
Clonazepam
The risk or severity of adverse effects can be increased when Clonazepam is combined with Milnacipran.
Clonidine
Milnacipran may increase the tachycardic activities of Clonidine.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Milnacipran.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Milnacipran.
Clozapine
The serum concentration of Clozapine can be increased when it is combined with Milnacipran.
Cocaine
The risk or severity of adverse effects can be increased when Cocaine is combined with Milnacipran.
Codeine
Codeine may increase the serotonergic activities of Milnacipran.
Codeine Anhydrous
Codeine may increase the serotonergic activities of Milnacipran.
CODEINE POLISTIREX
Codeine may increase the serotonergic activities of Milnacipran.
Cyamemazine
The risk or severity of adverse effects can be increased when Milnacipran is combined with Cyamemazine.
Cyclizine
The risk or severity of adverse effects can be increased when Cyclizine is combined with Milnacipran.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Milnacipran.
Cyclopenthiazide
Milnacipran may increase the hyponatremic activities of Cyclopenthiazide.
Cyproheptadine
The therapeutic efficacy of Milnacipran can be decreased when used in combination with Cyproheptadine.
Dantrolene
The risk or severity of adverse effects can be increased when Dantrolene is combined with Milnacipran.
Dapagliflozin
Milnacipran may increase the hypoglycemic activities of Dapagliflozin.
Dapiprazole
The risk or severity of adverse effects can be increased when Dapiprazole is combined with Milnacipran.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Milnacipran.
Desipramine
The risk or severity of adverse effects can be increased when Desipramine is combined with Milnacipran.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Milnacipran.
Desmopressin
The risk or severity of adverse effects can be increased when Milnacipran is combined with Desmopressin.
Desvenlafaxine
Desvenlafaxine may increase the serotonergic activities of Milnacipran.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Milnacipran.
Dexketoprofen
Milnacipran may increase the antiplatelet activities of Dexketoprofen.
Dexmedetomidine
Milnacipran may increase the tachycardic activities of Dexmedetomidine.
Dextromethorphan
Milnacipran may increase the serotonergic activities of Dextromethorphan.
Dextromoramide
Dextromoramide may increase the serotonergic activities of Milnacipran.
Dezocine
Dezocine may increase the serotonergic activities of Milnacipran.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Milnacipran.
Dibucaine
The risk or severity of adverse effects can be increased when Cinchocaine is combined with Milnacipran.
Diclofenac
Milnacipran may increase the antiplatelet activities of Diclofenac.
Dicumarol
The risk or severity of adverse effects can be increased when Milnacipran is combined with Dicoumarol.
Difenoxin
The risk or severity of adverse effects can be increased when Difenoxin is combined with Milnacipran.
Diflunisal
Milnacipran may increase the antiplatelet activities of Diflunisal.
Digoxin
The risk or severity of adverse effects can be increased when Milnacipran is combined with Digoxin.
Dihydrocodeine
Dihydrocodeine may increase the serotonergic activities of Milnacipran.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Milnacipran.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Milnacipran.
Diphenhydramine
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Milnacipran.
Diphenoxylate
Diphenoxylate may increase the serotonergic activities of Milnacipran.
Dipivefrin
Milnacipran may increase the tachycardic activities of Dipivefrin.
Disopyramide
Milnacipran may increase the hypoglycemic activities of Disopyramide.
Dobutamine
Milnacipran may increase the tachycardic activities of Dobutamine.
Dolasetron
Dolasetron may increase the serotonergic activities of Milnacipran.
Dopexamine
Milnacipran may increase the tachycardic activities of Dopexamine.
Dothiepin
The serum concentration of Dosulepin can be increased when it is combined with Milnacipran.
Doxepin
The risk or severity of adverse effects can be increased when Doxepin is combined with Milnacipran.
Doxylamine
The risk or severity of adverse effects can be increased when Doxylamine is combined with Milnacipran.
Droperidol
The risk or severity of adverse effects can be increased when Droperidol is combined with Milnacipran.
Drospirenone
Milnacipran may increase the antiplatelet activities of Drospirenone.
Droxicam
Milnacipran may increase the antiplatelet activities of Droxicam.
Droxidopa
Milnacipran may increase the tachycardic activities of Droxidopa.
Dulaglutide
Milnacipran may increase the hypoglycemic activities of Dulaglutide.
Duloxetine
Duloxetine may increase the serotonergic activities of Milnacipran.
Dyclonine
The risk or severity of adverse effects can be increased when Dyclonine is combined with Milnacipran.
Efavirenz
The risk or severity of adverse effects can be increased when Efavirenz is combined with Milnacipran.
Eicosapentaenoic Acid
Milnacipran may increase the antiplatelet activities of Icosapent.
Eletriptan
The risk or severity of adverse effects can be increased when Eletriptan is combined with Milnacipran.
Empagliflozin
Milnacipran may increase the hypoglycemic activities of Empagliflozin.
Enflurane
The risk or severity of adverse effects can be increased when Enflurane is combined with Milnacipran.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Milnacipran.
Ephedrine
Milnacipran may increase the tachycardic activities of Ephedrine.
Epinastine
Milnacipran may increase the tachycardic activities of Epinastine.
Epinephrine
Milnacipran may increase the tachycardic activities of Epinephrine.
ergoloid mesylates, USP
The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Milnacipran.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Milnacipran.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Milnacipran.
Escitalopram
Milnacipran may increase the serotonergic activities of Escitalopram.
Esmolol
The serum concentration of Esmolol can be increased when it is combined with Milnacipran.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Milnacipran.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Milnacipran.
Etanercept
Milnacipran may increase the antiplatelet activities of Etanercept.
Ethanol
The risk or severity of adverse effects can be increased when Ethanol is combined with Milnacipran.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Milnacipran.
Ethosuximide
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Milnacipran.
Ethotoin
The risk or severity of adverse effects can be increased when Ethotoin is combined with Milnacipran.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Ethyl chloride is combined with Milnacipran.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Milnacipran.
Ethylmorphine
Ethylmorphine may increase the serotonergic activities of Milnacipran.
Etidocaine
The risk or severity of adverse effects can be increased when Etidocaine is combined with Milnacipran.
Etifoxine
The risk or severity of adverse effects can be increased when Etifoxine is combined with Milnacipran.
Etilefrine
Milnacipran may increase the tachycardic activities of Etilefrine.
Etodolac
Milnacipran may increase the antiplatelet activities of Etodolac.
Etomidate
Milnacipran may increase the tachycardic activities of Etomidate.
Etoricoxib
Milnacipran may increase the antiplatelet activities of Etoricoxib.
Exenatide
Milnacipran may increase the hypoglycemic activities of Exenatide.
Ezogabine
The risk or severity of adverse effects can be increased when Ezogabine is combined with Milnacipran.
Felbamate
The risk or severity of adverse effects can be increased when Felbamate is combined with Milnacipran.
Fenfluramine
Milnacipran may increase the serotonergic activities of Fenfluramine.
Fenoprofen
Milnacipran may increase the antiplatelet activities of Fenoprofen.
Fenoterol
Milnacipran may increase the tachycardic activities of Fenoterol.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Milnacipran.
Fexofenadine
The risk or severity of adverse effects can be increased when Fexofenadine is combined with Milnacipran.
Fish Oils
Milnacipran may increase the antiplatelet activities of Fish oil.
Flibanserin
The risk or severity of adverse effects can be increased when Flibanserin is combined with Milnacipran.
Fluindione
The risk or severity of adverse effects can be increased when Milnacipran is combined with Fluindione.
Flunarizine
The risk or severity of adverse effects can be increased when Flunarizine is combined with Milnacipran.
Flunitrazepam
The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Milnacipran.
Fluoxetine
Milnacipran may increase the serotonergic activities of Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Milnacipran.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Milnacipran.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Milnacipran.
Flurbiprofen
Milnacipran may increase the antiplatelet activities of Flurbiprofen.
Fluspirilene
The risk or severity of adverse effects can be increased when Fluspirilene is combined with Milnacipran.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Milnacipran.
Fluvoxamine
Milnacipran may increase the serotonergic activities of Fluvoxamine.
Formoterol
Milnacipran may increase the tachycardic activities of Formoterol.
Fosphenytoin
The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Milnacipran.
Fospropofol
The risk or severity of adverse effects can be increased when Fospropofol is combined with Milnacipran.
Frovatriptan
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Milnacipran.
Furazolidone
Furazolidone may increase the serotonergic activities of Milnacipran.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Milnacipran.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Gabapentin Enacarbil is combined with Milnacipran.
Galantamine
The metabolism of Galantamine can be decreased when combined with Milnacipran.
Ginseng Preparation
Milnacipran may increase the antiplatelet activities of Ginseng.
Gliclazide
Milnacipran may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Milnacipran may increase the hypoglycemic activities of Glimepiride.
Glipizide
Milnacipran may increase the hypoglycemic activities of Glipizide.
Glutethimide
The risk or severity of adverse effects can be increased when Glutethimide is combined with Milnacipran.
Glyburide
Milnacipran may increase the hypoglycemic activities of Glyburide.
Granisetron
Granisetron may increase the serotonergic activities of Milnacipran.
Guanabenz
Milnacipran may increase the tachycardic activities of Guanabenz.
Guanfacine
Milnacipran may increase the tachycardic activities of Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Halazepam is combined with Milnacipran.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Milnacipran.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Milnacipran.
Heroin
Heroin may increase the serotonergic activities of Milnacipran.
Hexobarbital
The risk or severity of adverse effects can be increased when Hexobarbital is combined with Milnacipran.
Hexoprenaline
Milnacipran may increase the tachycardic activities of Hexoprenaline.
Hydrochlorothiazide
Milnacipran may increase the hyponatremic activities of Hydrochlorothiazide.
Hydrocodone
Hydrocodone may increase the serotonergic activities of Milnacipran.
HYDROCODONE POLISTIREX
Hydrocodone may increase the serotonergic activities of Milnacipran.
Hydroflumethiazide
Milnacipran may increase the hyponatremic activities of Hydroflumethiazide.
Hydromorphone
Hydromorphone may increase the serotonergic activities of Milnacipran.
Hydroxyzine
The risk or severity of adverse effects can be increased when Hydroxyzine is combined with Milnacipran.
Ibuprofen
Milnacipran may increase the antiplatelet activities of Ibuprofen.
Iloperidone
The risk or severity of adverse effects can be increased when Milnacipran is combined with Iloperidone.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Milnacipran.
Indacaterol
Milnacipran may increase the tachycardic activities of Indacaterol.
Indapamide
Milnacipran may increase the hyponatremic activities of Indapamide.
Indomethacin
Milnacipran may increase the antiplatelet activities of Indomethacin.
Insulin Detemir
Milnacipran may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Milnacipran may increase the hypoglycemic activities of Insulin Glargine.
insulin human, rDNA origin
Milnacipran may increase the hypoglycemic activities of Insulin Human.
Insulin Lispro
Milnacipran may increase the hypoglycemic activities of Insulin Lispro.
Insulin, Aspart Protamine, Human
Milnacipran may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Milnacipran may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Milnacipran may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Protamine Lispro, Human
Milnacipran may increase the hypoglycemic activities of Insulin Lispro.
Ioflupane I-123
Milnacipran may decrease effectiveness of Ioflupane I-123 as a diagnostic agent.
Iproniazid
Iproniazid may increase the serotonergic activities of Milnacipran.
Isocarboxazid
The therapeutic efficacy of Milnacipran can be increased when used in combination with Isocarboxazid.
Isoetharine
Milnacipran may increase the tachycardic activities of Isoetarine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Milnacipran.
Isometheptene
Milnacipran may increase the tachycardic activities of Isometheptene.
Isoproterenol
Milnacipran may increase the tachycardic activities of Isoprenaline.
Isoxsuprine
Milnacipran may increase the tachycardic activities of Isoxsuprine.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Milnacipran.
Ketazolam
The risk or severity of adverse effects can be increased when Ketazolam is combined with Milnacipran.
Ketoprofen
Milnacipran may increase the antiplatelet activities of Ketoprofen.
Ketorolac
Milnacipran may increase the antiplatelet activities of Ketorolac.
Korean ginseng preparation
Milnacipran may increase the antiplatelet activities of Ginseng.
KOREAN GINSENG ROOT
Milnacipran may increase the antiplatelet activities of Ginseng.
Korean Ginseng Root Extract
Milnacipran may increase the antiplatelet activities of Ginseng.
Labetalol
The serum concentration of Labetalol can be increased when it is combined with Milnacipran.
Lamotrigine
The risk or severity of adverse effects can be increased when Milnacipran is combined with Lamotrigine.
Levalbuterol
Milnacipran may increase the tachycardic activities of Levosalbutamol.
Levetiracetam
The risk or severity of adverse effects can be increased when Levetiracetam is combined with Milnacipran.
Levobetaxolol
The serum concentration of Levobetaxolol can be increased when it is combined with Milnacipran.
Levobunolol
The serum concentration of Levobunolol can be increased when it is combined with Milnacipran.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Milnacipran.
Levocabastine
The risk or severity of adverse effects can be increased when Levocabastine is combined with Milnacipran.
Levocetirizine
The risk or severity of adverse effects can be increased when Levocetirizine is combined with Milnacipran.
Levodopa
The risk or severity of adverse effects can be increased when Levodopa is combined with Milnacipran.
Levomethadyl
Levomethadyl Acetate may increase the serotonergic activities of Milnacipran.
Levomilnacipran
Milnacipran may increase the serotonergic activities of Levomilnacipran.
Levonordefrin
Milnacipran may decrease the antihypertensive activities of Levonordefrin.
Levorphanol
Levorphanol may increase the serotonergic activities of Milnacipran.
Levothyroxine
The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Milnacipran.
Lidocaine
The risk or severity of adverse effects can be increased when Lidocaine is combined with Milnacipran.
Linezolid
Linezolid may increase the serotonergic activities of Milnacipran.
Liothyronine
The therapeutic efficacy of Liothyronine can be decreased when used in combination with Milnacipran.
Liraglutide
Milnacipran may increase the hypoglycemic activities of Liraglutide.
Lithium
Lithium may increase the serotonergic activities of Milnacipran.
Lithium Cation
Lithium may increase the serotonergic activities of Milnacipran.
Lofexidine
Milnacipran may increase the tachycardic activities of Lofexidine.
Loratadine
The risk or severity of adverse effects can be increased when Loratadine is combined with Milnacipran.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Milnacipran.
Lorcaserin
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Milnacipran.
Lormetazepam
The risk or severity of adverse effects can be increased when Lormetazepam is combined with Milnacipran.
Lornoxicam
Milnacipran may increase the antiplatelet activities of Lornoxicam.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Milnacipran.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Milnacipran.
Magnesium Salicylate
Milnacipran may increase the antiplatelet activities of Magnesium salicylate.
Magnesium Sulfate
The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Milnacipran.
MAGNESIUM SULFATE ANHYDROUS
The risk or severity of adverse effects can be increased when Magnesium sulfate is combined with Milnacipran.
Maprotiline
The risk or severity of adverse effects can be increased when Maprotiline is combined with Milnacipran.
Mecasermin
Milnacipran may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Milnacipran may increase the hypoglycemic activities of Mecasermin.
Meclizine
The risk or severity of adverse effects can be increased when Meclizine is combined with Milnacipran.
Meclofenamate
Milnacipran may increase the antiplatelet activities of Meclofenamic acid.
Meclofenamic Acid
Milnacipran may increase the antiplatelet activities of Meclofenamic acid.
Mefenamic Acid
Milnacipran may increase the antiplatelet activities of Mefenamic acid.
Melatonin
The risk or severity of adverse effects can be increased when Melatonin is combined with Milnacipran.
Meloxicam
Milnacipran may increase the antiplatelet activities of Meloxicam.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Milnacipran.
Mephentermine
Milnacipran may increase the tachycardic activities of Mephentermine.
Mephobarbital
The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Milnacipran.
Mepindolol
The serum concentration of Mepindolol can be increased when it is combined with Milnacipran.
Mepivacaine
The risk or severity of adverse effects can be increased when Mepivacaine is combined with Milnacipran.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Milnacipran.
Mesalamine
Milnacipran may increase the antiplatelet activities of Mesalazine.
Mesoridazine
The risk or severity of adverse effects can be increased when Mesoridazine is combined with Milnacipran.
Metaproterenol
Milnacipran may increase the tachycardic activities of Orciprenaline.
Metaraminol
Milnacipran may increase the tachycardic activities of Metaraminol.
Metaxalone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Milnacipran.
Metformin
Milnacipran may increase the hypoglycemic activities of Metformin.
Methadone
The metabolism of Methadone can be decreased when combined with Milnacipran.
Methadyl Acetate
Methadyl Acetate may increase the serotonergic activities of Milnacipran.
Methamphetamine
Milnacipran may increase the tachycardic activities of Methamphetamine.
Methapyrilene
The risk or severity of adverse effects can be increased when Methapyrilene is combined with Milnacipran.
Methaqualone
The risk or severity of adverse effects can be increased when Methaqualone is combined with Milnacipran.
Methocarbamol
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Milnacipran.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Milnacipran.
Methotrimeprazine
The risk or severity of adverse effects can be increased when Methotrimeprazine is combined with Milnacipran.
Methoxamine
Milnacipran may increase the tachycardic activities of Methoxamine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Milnacipran.
Methsuximide
The risk or severity of adverse effects can be increased when Methsuximide is combined with Milnacipran.
Methyclothiazide
Milnacipran may increase the hyponatremic activities of Methyclothiazide.
Methyldopa
Milnacipran may increase the tachycardic activities of Methyldopa.
METHYLDOPA ANHYDROUS
Milnacipran may increase the tachycardic activities of Methyldopa.
Methylene blue
Milnacipran may increase the serotonergic activities of Methylene blue.
METHYLEPHEDRINE, DL-
Milnacipran may increase the tachycardic activities of DL-Methylephedrine.
Metipranolol
The serum concentration of Metipranolol can be increased when it is combined with Milnacipran.
Metoclopramide
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Milnacipran.
Metolazone
Milnacipran may increase the hyponatremic activities of Metolazone.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Milnacipran.
Metylperon
The risk or severity of adverse effects can be increased when Melperone is combined with Milnacipran.
Metyrosine
The risk or severity of adverse effects can be increased when Metyrosine is combined with Milnacipran.
Mexiletine
The metabolism of Mexiletine can be decreased when combined with Milnacipran.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Milnacipran.
Midodrine
Milnacipran may increase the tachycardic activities of Midodrine.
Mifepristone
Milnacipran may increase the hypoglycemic activities of Mifepristone.
Miglitol
Milnacipran may increase the hypoglycemic activities of Miglitol.
Minaprine
Minaprine may increase the serotonergic activities of Milnacipran.
Mirabegron
Milnacipran may increase the tachycardic activities of Mirabegron.
Mirtazapine
The risk or severity of adverse effects can be increased when Mirtazapine is combined with Milnacipran.
Moclobemide
The risk or severity of adverse effects can be increased when Milnacipran is combined with Moclobemide.
Molindone
The risk or severity of adverse effects can be increased when Molindone is combined with Milnacipran.
Moricizine
The risk or severity of adverse effects can be increased when Moricizine is combined with Milnacipran.
Morniflumate
Milnacipran may increase the antiplatelet activities of Morniflumate.
Morphine
Morphine may increase the serotonergic activities of Milnacipran.
Moxonidine
Milnacipran may increase the tachycardic activities of Moxonidine.
N-methylephedrine
Milnacipran may increase the tachycardic activities of DL-Methylephedrine.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Milnacipran.
Nabumetone
Milnacipran may increase the antiplatelet activities of Nabumetone.
Nadolol
The serum concentration of Nadolol can be increased when it is combined with Milnacipran.
Nalbuphine
Nalbuphine may increase the serotonergic activities of Milnacipran.
Naphazoline
Milnacipran may increase the tachycardic activities of Naphazoline.
Naproxen
Milnacipran may increase the antiplatelet activities of Naproxen.
Naratriptan
The risk or severity of adverse effects can be increased when Naratriptan is combined with Milnacipran.
Nateglinide
Milnacipran may increase the hypoglycemic activities of Nateglinide.
Nebivolol
Milnacipran may increase the tachycardic activities of Nebivolol.
Nefazodone
Nefazodone may increase the serotonergic activities of Milnacipran.
Nepafenac
Milnacipran may increase the antiplatelet activities of Nepafenac.
Nialamide
Nialamide may increase the serotonergic activities of Milnacipran.
Niflumic Acid
Milnacipran may increase the antiplatelet activities of Niflumic Acid.
Nimesulide
Milnacipran may increase the antiplatelet activities of Nimesulide.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Milnacipran.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Milnacipran.
Nordazepam
The risk or severity of adverse effects can be increased when Nordazepam is combined with Milnacipran.
Norepinephrine
Milnacipran may increase the tachycardic activities of Norepinephrine.
Norflurane
The risk or severity of adverse effects can be increased when Norflurane is combined with Milnacipran.
Normethadone
Normethadone may increase the serotonergic activities of Milnacipran.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Milnacipran.
Nylidrin
Milnacipran may increase the tachycardic activities of Nylidrin.
Olanzapine
Milnacipran may increase the serotonergic activities of Olanzapine.
Olodaterol
Milnacipran may increase the tachycardic activities of Olodaterol.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Milnacipran.
Ondansetron
The risk or severity of adverse effects can be increased when Ondansetron is combined with Milnacipran.
Opium
Opium may increase the serotonergic activities of Milnacipran.
Orphenadrine
The risk or severity of adverse effects can be increased when Orphenadrine is combined with Milnacipran.
Oxaprozin
Milnacipran may increase the antiplatelet activities of Oxaprozin.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Milnacipran.
Oxprenolol
The serum concentration of Oxprenolol can be increased when it is combined with Milnacipran.
Oxycodone
Oxycodone may increase the serotonergic activities of Milnacipran.
Oxymetazoline
Milnacipran may increase the tachycardic activities of Oxymetazoline.
Oxymorphone
Oxymorphone may increase the serotonergic activities of Milnacipran.
Paliperidone
Milnacipran may increase the tachycardic activities of Paliperidone.
Palonosetron
Palonosetron may increase the serotonergic activities of Milnacipran.
Paraldehyde
The risk or severity of adverse effects can be increased when Paraldehyde is combined with Milnacipran.
Parecoxib
Milnacipran may increase the antiplatelet activities of Parecoxib.
Paregoric
Morphine may increase the serotonergic activities of Milnacipran.
Pargyline
Pargyline may increase the serotonergic activities of Milnacipran.
Paroxetine
Milnacipran may increase the serotonergic activities of Paroxetine.
Penbutolol
The serum concentration of Penbutolol can be increased when it is combined with Milnacipran.
Pentamidine
Milnacipran may increase the hypoglycemic activities of Pentamidine.
Pentazocine
Pentazocine may increase the serotonergic activities of Milnacipran.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Milnacipran.
Perampanel
The risk or severity of adverse effects can be increased when Perampanel is combined with Milnacipran.
Perazine
The risk or severity of adverse effects can be increased when Perazine is combined with Milnacipran.
Pergolide
Milnacipran may increase the tachycardic activities of Pergolide.
Periciazine
The risk or severity of adverse effects can be increased when Propericiazine is combined with Milnacipran.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Milnacipran.
Phendimetrazine
Milnacipran may increase the tachycardic activities of Phendimetrazine.
Phenelzine
The risk or severity of adverse effects can be increased when Milnacipran is combined with Phenelzine.
Phenindione
The risk or severity of adverse effects can be increased when Milnacipran is combined with Phenindione.
Phenobarbital
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Milnacipran.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Phenoxyethanol is combined with Milnacipran.
Phenprocoumon
The risk or severity of adverse effects can be increased when Milnacipran is combined with Phenprocoumon.
Phenylbutazone
Milnacipran may increase the antiplatelet activities of Phenylbutazone.
Phenylephrine
Milnacipran may increase the tachycardic activities of Phenylephrine.
Phenylpropanolamine
Milnacipran may increase the tachycardic activities of Phenylpropanolamine.
Phenytoin
The risk or severity of adverse effects can be increased when Phenytoin is combined with Milnacipran.
Pimozide
The risk or severity of adverse effects can be increased when Pimozide is combined with Milnacipran.
Pindolol
Milnacipran may increase the tachycardic activities of Pindolol.
Pioglitazone
Milnacipran may increase the hypoglycemic activities of Pioglitazone.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Milnacipran.
Pipothiazine
The risk or severity of adverse effects can be increased when Milnacipran is combined with Pipotiazine.
Pirbuterol
Milnacipran may increase the tachycardic activities of Pirbuterol.
Pirinitramide
Piritramide may increase the serotonergic activities of Milnacipran.
Piroxicam
Milnacipran may increase the antiplatelet activities of Piroxicam.
Piroxicam-Beta-Cyclodextrin
Milnacipran may increase the antiplatelet activities of Piroxicam.
Pizotyline
The risk or severity of adverse effects can be increased when Pizotifen is combined with Milnacipran.
Polythiazide
Milnacipran may increase the hyponatremic activities of Polythiazide.
Pomalidomide
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Milnacipran.
Practolol
The serum concentration of Practolol can be increased when it is combined with Milnacipran.
Pramlintide
Milnacipran may increase the hypoglycemic activities of Pramlintide.
Pramoxine
The risk or severity of adverse effects can be increased when Pramocaine is combined with Milnacipran.
Prazepam
The risk or severity of adverse effects can be increased when Prazepam is combined with Milnacipran.
Pregabalin
The risk or severity of adverse effects can be increased when Pregabalin is combined with Milnacipran.
Prilocaine
The risk or severity of adverse effects can be increased when Prilocaine is combined with Milnacipran.
Primidone
The risk or severity of adverse effects can be increased when Primidone is combined with Milnacipran.
Procaine
The risk or severity of adverse effects can be increased when Milnacipran is combined with Procaine.
Procarbazine
The risk or severity of adverse effects can be increased when Milnacipran is combined with Procarbazine.
Procaterol
Milnacipran may increase the tachycardic activities of Procaterol.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Milnacipran.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Milnacipran.
Promethazine
The risk or severity of adverse effects can be increased when Promethazine is combined with Milnacipran.
Propafenone
The serum concentration of Propafenone can be increased when it is combined with Milnacipran.
Proparacaine
The risk or severity of adverse effects can be increased when Proparacaine is combined with Milnacipran.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Milnacipran.
Propoxyphene
Dextropropoxyphene may increase the serotonergic activities of Milnacipran.
Propranolol
The serum concentration of Propranolol can be increased when it is combined with Milnacipran.
Prothipendyl
The risk or severity of adverse effects can be increased when Milnacipran is combined with Prothipendyl.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Milnacipran.
Pseudoephedrine
Milnacipran may increase the tachycardic activities of Pseudoephedrine.
Quazepam
The risk or severity of adverse effects can be increased when Quazepam is combined with Milnacipran.
Quetiapine
The risk or severity of adverse effects can be increased when Quetiapine is combined with Milnacipran.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Quetiapine is combined with Milnacipran.
Quinethazone
Milnacipran may increase the hyponatremic activities of Quinethazone.
Quinine
Milnacipran may increase the hypoglycemic activities of Quinine.
Racepinephrine
Milnacipran may increase the tachycardic activities of Racepinephrine.
Ramelteon
The risk or severity of adverse effects can be increased when Ramelteon is combined with Milnacipran.
Rasagiline
The risk or severity of adverse effects can be increased when Milnacipran is combined with Rasagiline.
Regular Insulin, Human
Milnacipran may increase the hypoglycemic activities of Insulin Human.
Remifentanil
Remifentanil may increase the serotonergic activities of Milnacipran.
Remoxipride
The risk or severity of adverse effects can be increased when Remoxipride is combined with Milnacipran.
Repaglinide
Milnacipran may increase the hypoglycemic activities of Repaglinide.
Reproterol
Milnacipran may increase the tachycardic activities of Reproterol.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Milnacipran.
Resveratrol
Milnacipran may increase the antiplatelet activities of Resveratrol.
Rilmenidine
Milnacipran may increase the tachycardic activities of Rilmenidine.
Risperidone
The metabolism of Risperidone can be decreased when combined with Milnacipran.
Ritodrine
Milnacipran may increase the tachycardic activities of Ritodrine.
Rizatriptan
The risk or severity of adverse effects can be increased when Rizatriptan is combined with Milnacipran.
Rofecoxib
Milnacipran may increase the antiplatelet activities of Rofecoxib.
Ropinirole
Milnacipran may increase the tachycardic activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Milnacipran.
Rosiglitazone
Milnacipran may increase the hypoglycemic activities of Rosiglitazone.
Salicylic Acid
Milnacipran may increase the antiplatelet activities of Salicylic acid.
Salmeterol
Milnacipran may increase the tachycardic activities of Salmeterol.
Salsalate
Milnacipran may increase the antiplatelet activities of Salsalate.
Saxagliptin
Milnacipran may increase the hypoglycemic activities of Saxagliptin.
Saxagliptin Anhydrous
Milnacipran may increase the hypoglycemic activities of Saxagliptin.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Milnacipran.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Milnacipran.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Milnacipran.
Selegiline
The risk or severity of adverse effects can be increased when Milnacipran is combined with Selegiline.
Sertindole
The risk or severity of adverse effects can be increased when Sertindole is combined with Milnacipran.
Sertraline
Milnacipran may increase the serotonergic activities of Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Milnacipran.
Sitagliptin
Milnacipran may increase the hypoglycemic activities of Sitagliptin.
Sitagliptin Phosphate
Milnacipran may increase the hypoglycemic activities of Sitagliptin.
Sodium Oxybate
The risk or severity of adverse effects can be increased when Sodium oxybate is combined with Milnacipran.
Sotalol
The serum concentration of Sotalol can be increased when it is combined with Milnacipran.
Sufentanil
Sufentanil may increase the serotonergic activities of Milnacipran.
Sulfadiazine
Milnacipran may increase the hypoglycemic activities of Sulfadiazine.
Sulfamethoxazole
Milnacipran may increase the hypoglycemic activities of Sulfamethoxazole.
Sulfasalazine
Milnacipran may increase the antiplatelet activities of Sulfasalazine.
Sulfisoxazole
Milnacipran may increase the hypoglycemic activities of Sulfisoxazole.
Sulindac
Milnacipran may increase the antiplatelet activities of Sulindac.
Sulpiride
The risk or severity of adverse effects can be increased when Sulpiride is combined with Milnacipran.
Sumatriptan
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Milnacipran.
Sumatriptan Succinate
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Milnacipran.
Sunitinib
Milnacipran may increase the hypoglycemic activities of Sunitinib.
Suprofen
Milnacipran may increase the antiplatelet activities of Suprofen.
Suvorexant
The risk or severity of adverse effects can be increased when Suvorexant is combined with Milnacipran.
Synephrine
Milnacipran may increase the tachycardic activities of Synephrine.
Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Milnacipran.
Talinolol
The serum concentration of Talinolol can be increased when it is combined with Milnacipran.
Talniflumate
Milnacipran may increase the antiplatelet activities of Talniflumate.
Tapentadol
The risk or severity of adverse effects can be increased when Milnacipran is combined with Tapentadol.
Tasimelteon
The risk or severity of adverse effects can be increased when Tasimelteon is combined with Milnacipran.
Tedizolid
Tedizolid Phosphate may increase the serotonergic activities of Milnacipran.
Tedizolid Phosphate
Tedizolid Phosphate may increase the serotonergic activities of Milnacipran.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Milnacipran.
Tenoxicam
Milnacipran may increase the antiplatelet activities of Tenoxicam.
Terbutaline
Milnacipran may increase the tachycardic activities of Terbutaline.
Terbutaline Sulfate
Milnacipran may increase the tachycardic activities of Terbutaline.
Tertatolol
The serum concentration of Tertatolol can be increased when it is combined with Milnacipran.
Tetrabenazine
The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Milnacipran.
Tetracaine
The risk or severity of adverse effects can be increased when Tetracaine is combined with Milnacipran.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Tetracaine is combined with Milnacipran.
Tetrahydrozoline
Milnacipran may increase the tachycardic activities of Tetryzoline.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Milnacipran.
Thiamylal
The risk or severity of adverse effects can be increased when Thiamylal is combined with Milnacipran.
Thiethylperazine
The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Milnacipran.
Thiopental
The risk or severity of adverse effects can be increased when Thiopental is combined with Milnacipran.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Thiopental is combined with Milnacipran.
Thioproperazine
The risk or severity of adverse effects can be increased when Thioproperazine is combined with Milnacipran.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Milnacipran.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Milnacipran.
Thyroid, Porcine
The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Milnacipran.
Tiagabine
The risk or severity of adverse effects can be increased when Tiagabine is combined with Milnacipran.
Tiapride
The risk or severity of adverse effects can be increased when Tiapride is combined with Milnacipran.
Tiaprofenic Acid
Milnacipran may increase the antiplatelet activities of Tiaprofenic acid.
Timolol
The serum concentration of Timolol can be increased when it is combined with Milnacipran.
Timolol Anhydrous
The serum concentration of Timolol can be increased when it is combined with Milnacipran.
Tizanidine
Milnacipran may increase the tachycardic activities of Tizanidine.
Tolazamide
Milnacipran may increase the hypoglycemic activities of Tolazamide.
Tolbutamide
Milnacipran may increase the hypoglycemic activities of Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Milnacipran.
Tolmetin
Milnacipran may increase the antiplatelet activities of Tolmetin.
Toloxatone
Toloxatone may increase the serotonergic activities of Milnacipran.
Topiramate
The risk or severity of adverse effects can be increased when Topiramate is combined with Milnacipran.
Tramadol
Milnacipran may increase the neuroexcitatory activities of Tramadol.
Tranylcypromine
The risk or severity of adverse effects can be increased when Milnacipran is combined with Tranylcypromine.
Trazodone
Milnacipran may increase the serotonergic activities of Trazodone.
Triamcinolone
Milnacipran may increase the antiplatelet activities of Triamcinolone.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Milnacipran.
Triazulenone
The risk or severity of adverse effects can be increased when Loprazolam is combined with Milnacipran.
Trichlormethiazide
Milnacipran may increase the hyponatremic activities of Trichlormethiazide.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Milnacipran.
Triflupromazine
The risk or severity of adverse effects can be increased when Triflupromazine is combined with Milnacipran.
Trimeprazine
The risk or severity of adverse effects can be increased when Alimemazine is combined with Milnacipran.
Trimipramine
The risk or severity of adverse effects can be increased when Trimipramine is combined with Milnacipran.
Triprolidine
The risk or severity of adverse effects can be increased when Triprolidine is combined with Milnacipran.
Trolamine Salicylate
Milnacipran may increase the antiplatelet activities of Trolamine salicylate.
Tropisetron
Tropisetron may increase the serotonergic activities of Milnacipran.
Tryptophan
L-Tryptophan may increase the serotonergic activities of Milnacipran.
Tulobuterol
Milnacipran may increase the tachycardic activities of Tulobuterol.
Urethane
The risk or severity of adverse effects can be increased when Ethyl carbamate is combined with Milnacipran.
Valdecoxib
Milnacipran may increase the antiplatelet activities of Valdecoxib.
Valproate
The risk or severity of adverse effects can be increased when Valproic Acid is combined with Milnacipran.
Valproic Acid
The risk or severity of adverse effects can be increased when Valproic Acid is combined with Milnacipran.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Milnacipran.
Venlafaxine
Venlafaxine may increase the serotonergic activities of Milnacipran.
Vigabatrin
The risk or severity of adverse effects can be increased when Vigabatrin is combined with Milnacipran.
Vilanterol
Milnacipran may increase the tachycardic activities of Vilanterol.
Vilazodone
Milnacipran may increase the serotonergic activities of Vilazodone.
Vortioxetine
Milnacipran may increase the serotonergic activities of Vortioxetine.
Warfarin
The risk or severity of adverse effects can be increased when Milnacipran is combined with Warfarin.
Xamoterol
Milnacipran may increase the tachycardic activities of Xamoterol.
Xylazine
Milnacipran may increase the tachycardic activities of Xylazine.
Xylometazoline
Milnacipran may increase the tachycardic activities of Xylometazoline.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Milnacipran.
Ziconotide
The risk or severity of adverse effects can be increased when Ziconotide is combined with Milnacipran.
Ziprasidone
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Milnacipran.
Zolmitriptan
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Milnacipran.
Zolpidem
The risk or severity of adverse effects can be increased when Zolpidem is combined with Milnacipran.
Zonisamide
The risk or severity of adverse effects can be increased when Zonisamide is combined with Milnacipran.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Milnacipran.
Zotepine
The risk or severity of adverse effects can be increased when Zotepine is combined with Milnacipran.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Milnacipran.
